These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35692186)

  • 1. Effect Compartment Model for the Evaluation of Tolerance to Psychological Highness Following Smoking Marijuana.
    Singla S; Block R
    J Clin Pharmacol; 2022 Dec; 62(12):1539-1547. PubMed ID: 35692186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable Delta-9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics After Cannabis Smoking in Regular Users.
    Liyanage M; Nikanjam M; Capparelli EV; Suhandynata RT; Fitzgerald RL; Marcotte TD; Grant I; Momper JD
    Ther Drug Monit; 2023 Oct; 45(5):689-696. PubMed ID: 37199428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users.
    Ramaekers JG; Theunissen EL; de Brouwer M; Toennes SW; Moeller MR; Kauert G
    Psychopharmacology (Berl); 2011 Mar; 214(2):391-401. PubMed ID: 21049267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC).
    Hunault CC; Mensinga TT; Böcker KB; Schipper CM; Kruidenier M; Leenders ME; de Vries I; Meulenbelt J
    Psychopharmacology (Berl); 2009 May; 204(1):85-94. PubMed ID: 19099294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relating Observed Psychoactive Effects to the Plasma Concentrations of Delta-9-Tetrahydrocannabinol and Its Active Metabolite: An Effect-Compartment Modeling Approach.
    Awasthi R; An G; Donovan MD; Boles Ponto LL
    J Pharm Sci; 2018 Feb; 107(2):745-755. PubMed ID: 28942005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose Estimation Utility in a Population Pharmacokinetic Analysis of Inhaled Δ9-Tetrahydrocannabinol Cannabis Market Products in Occasional and Daily Users.
    Henthorn TK; Wang GS; Dooley G; Brooks-Russell A; Wrobel J; Limbacher S; Kosnett M
    Ther Drug Monit; 2024 Oct; 46(5):672-680. PubMed ID: 39235358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetic modeling of plasma Δ9-tetrahydrocannabinol and an active and inactive metabolite following controlled smoked cannabis administration.
    Sempio C; Huestis MA; Mikulich-Gilbertson SK; Klawitter J; Christians U; Henthorn TK
    Br J Clin Pharmacol; 2020 Mar; 86(3):611-619. PubMed ID: 31747464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial.
    Hunault CC; Böcker KB; Stellato RK; Kenemans JL; de Vries I; Meulenbelt J
    Psychopharmacology (Berl); 2014 Dec; 231(24):4723-33. PubMed ID: 24879495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
    Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H
    Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
    Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
    Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
    Huestis MA; Cone EJ
    J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulated driving performance among daily and occasional cannabis users.
    Brooks-Russell A; Brown T; Friedman K; Wrobel J; Schwarz J; Dooley G; Ryall KA; Steinhart B; Amioka E; Milavetz G; Sam Wang G; Kosnett MJ
    Accid Anal Prev; 2021 Sep; 160():106326. PubMed ID: 34403895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
    Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Δ9-tetrahydrocannabinol (THC) is present in the body between smoking sessions in occasional non-daily cannabis users.
    Mørland J; Bramness JG
    Forensic Sci Int; 2020 Apr; 309():110188. PubMed ID: 32120192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users.
    van Wel JH; Kuypers KP; Theunissen EL; Toennes SW; Spronk DB; Verkes RJ; Ramaekers JG
    Br J Pharmacol; 2013 Dec; 170(7):1410-20. PubMed ID: 24106872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC.
    Hunault CC; Mensinga TT; de Vries I; Kelholt-Dijkman HH; Hoek J; Kruidenier M; Leenders ME; Meulenbelt J
    Psychopharmacology (Berl); 2008 Dec; 201(2):171-81. PubMed ID: 18695931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration.
    Newmeyer MN; Swortwood MJ; Taylor ME; Abulseoud OA; Woodward TH; Huestis MA
    J Appl Toxicol; 2017 Aug; 37(8):922-932. PubMed ID: 28138971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.
    Schlienz NJ; Lee DC; Stitzer ML; Vandrey R
    Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Smoked Cannabis on Vigilance and Accident Risk Using Simulated Driving in Occasional and Chronic Users and the Pharmacokinetic-Pharmacodynamic Relationship.
    Hartley S; Simon N; Larabi A; Vaugier I; Barbot F; Quera-Salva MA; Alvarez JC
    Clin Chem; 2019 May; 65(5):684-693. PubMed ID: 30872375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
    Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
    Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.